Literature DB >> 18989666

How to use myocardial 123I-MIBG scintigraphy in chronic heart failure.

Denis Agostini, Ignasi Carrio, Hein J Verberne.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 18989666     DOI： 10.1007/s00259-008-0976-x

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  23 in total

Review 1.  MIBG imaging.

Authors:  Amar D Patel; Ami E Iskandrian
Journal:  J Nucl Cardiol       Date:  2002 Jan-Feb       Impact factor: 5.952

2.  Prognostic value of MIBG imaging in idiopathic dilated cardiomyopathy.

Authors:  P Merlet; C Benvenuti; D Moyse; F Pouillart; J L Dubois-Randé; A M Duval; D Loisance; A Castaigne; A Syrota
Journal:  J Nucl Med       Date:  1999-06       Impact factor: 10.057

3.  I-123 MIBG imaging and heart rate variability analysis to predict the need for an implantable cardioverter defibrillator.

Authors:  Rishi Arora; Kevin J Ferrick; Tomoaki Nakata; Robert C Kaplan; Michael Rozengarten; Farhana Latif; Kaman Ng; Vanessa Marcano; Sherman Heller; John D Fisher; Mark I Travin
Journal:  J Nucl Cardiol       Date:  2003 Mar-Apr       Impact factor: 5.952

4.  Compton scatter compensation using the triple-energy window method for single- and dual-isotope SPECT.

Authors:  T Ichihara; K Ogawa; N Motomura; A Kubo; S Hashimoto
Journal:  J Nucl Med       Date:  1993-12       Impact factor: 10.057

Review 5.  Scatter correction in scintigraphy: the state of the art.

Authors:  I Buvat; H Benali; A Todd-Pokropek; R Di Paola
Journal:  Eur J Nucl Med       Date:  1994-07

6.  Cardiac metaiodobenzylguanidine uptake in patients with moderate chronic heart failure: relationship with peak oxygen uptake and prognosis.

Authors:  A Cohen-Solal; Y Esanu; D Logeart; F Pessione; C Dubois; G Dreyfus; R Gourgon; P Merlet
Journal:  J Am Coll Cardiol       Date:  1999-03       Impact factor: 24.094

7.  Effect of collimator choice on quantitative assessment of cardiac iodine 123 MIBG uptake.

Authors:  Yusuke Inoue; Akira Suzuki; Ichiro Shirouzu; Toru Machida; Yasunori Yoshizawa; Fumihide Akita; Satoshi Ohnishi; Kohki Yoshikawa; Kuni Ohtomo
Journal:  J Nucl Cardiol       Date:  2003 Nov-Dec       Impact factor: 5.952

8.  Cardiac metaiodobenzylguanidine activity can predict the long-term efficacy of angiotensin-converting enzyme inhibitors and/or beta-adrenoceptor blockers in patients with heart failure.

Authors:  Tomoaki Nakata; Takeru Wakabayashi; Michifumi Kyuma; Toru Takahashi; Kazufumi Tsuchihashi; Kazuaki Shimamoto
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-09-25       Impact factor: 9.236

9.  Incremental prognostic implications of brain natriuretic peptide, cardiac sympathetic nerve innervation, and noncardiac disorders in patients with heart failure.

Authors:  Michifumi Kyuma; Tomoaki Nakata; Akiyoshi Hashimoto; Kazuhiko Nagao; Hisataka Sasao; Toru Takahashi; Kazufumi Tsuchihashi; Kazuaki Shimamoto
Journal:  J Nucl Med       Date:  2004-02       Impact factor: 10.057

10.  Variations in 123I-metaiodobenzylguanidine (MIBG) late heart mediastinal ratios in chronic heart failure: a need for standardisation and validation.

Authors:  Hein J Verberne; Jan B A Habraken; Berthe L F van Eck-Smit; Denis Agostini; Arnold F Jacobson
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-10-06       Impact factor: 9.236
View more
  27 in total

1.  Myocardial (123) I-metaiodobenzylguanidine washout and heart rate variability in asymptomatic subjects.

Authors:  Sakari Simula; Esko Vanninen; Antti Hedman; Seppo Lehto; Jyrki Kuikka; Juha Hartikainen
Journal:  Ann Noninvasive Electrocardiol       Date:  2012-01       Impact factor: 1.468

2.  Diagnostic cutoff points for ¹²³I-MIBG myocardial scintigraphy in a Caucasian population with Parkinson's disease.

Authors:  Africa Muxí; Pilar Paredes; Ignacio Navales; Francesc Valldeoriola; Carles Gaig; Francisco Lomeña; Andres de la Cerda; Oriol Solà; Beatriz Domenech; Eduardo Tolosa; Francesca Pons
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-03-04       Impact factor: 9.236

3.  123I-mIBG and the phantom tollbooth.

Authors:  Albert Flotats; Ignasi Carrió
Journal:  J Nucl Cardiol       Date:  2017-03-13       Impact factor: 5.952

4.  Optimization of a simultaneous dual-isotope 201Tl/123I-MIBG myocardial SPECT imaging protocol with a CZT camera for trigger zone assessment after myocardial infarction for routine clinical settings: Are delayed acquisition and scatter correction necessary?

Authors:  Emmanuel D'estanque; Christophe Hedon; Benoît Lattuca; Aurélie Bourdon; Meriem Benkiran; Aurélie Verd; François Roubille; Denis Mariano-Goulart
Journal:  J Nucl Cardiol       Date:  2016-05-25       Impact factor: 5.952

5.  ASNC imaging guidelines for SPECT nuclear cardiology procedures: Stress, protocols, and tracers.

Authors:  Milena J Henzlova; W Lane Duvall; Andrew J Einstein; Mark I Travin; Hein J Verberne
Journal:  J Nucl Cardiol       Date:  2016-06       Impact factor: 5.952

6.  123I-mIBG: Simplicity and reproducibility.

Authors:  Kevin Curl; Christopher L Hansen
Journal:  J Nucl Cardiol       Date:  2018-01-29       Impact factor: 5.952

7.  Proposal for standardization of 123I-metaiodobenzylguanidine (MIBG) cardiac sympathetic imaging by the EANM Cardiovascular Committee and the European Council of Nuclear Cardiology.

Authors:  Albert Flotats; Ignasi Carrió; Denis Agostini; Dominique Le Guludec; Claudio Marcassa; Michael Schäfers; Michael Schaffers; G Aernout Somsen; Mustafa Unlu; Hein J Verberne
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-08       Impact factor: 9.236

8.  Significance of cardiac sympathetic nervous system abnormality for predicting vascular events in patients with idiopathic paroxysmal atrial fibrillation.

Authors:  Yasushi Akutsu; Kyouichi Kaneko; Yusuke Kodama; Hui-Ling Li; Jumpei Suyama; Akira Shinozuka; Takehiko Gokan; Mitsuharu Kawamura; Taku Asano; Yuji Hamazaki; Kaoru Tanno; Youichi Kobayashi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-12-17       Impact factor: 9.236

9.  Preoperative iodine-123 meta-iodobenzylguanidine imaging is a novel predictor of left ventricular reverse remodeling during treatment with a left ventricular assist device.

Authors:  Teruhiko Imamura; Koichiro Kinugawa; Daisuke Nitta; Osamu Kinoshita; Kan Nawata; Minoru Ono
Journal:  J Artif Organs       Date:  2015-07-29       Impact factor: 1.731

10.  Impact of mediastinal, liver and lung (123)I-metaiodobenzylguanidine ( (123)I-MIBG) washout on calculated (123)I-MIBG myocardial washout.

Authors:  Hein J Verberne; G Aernout Somsen; Pavol Povinec; Berthe L F van Eck-Smit; Arnold F Jacobson
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-03-04       Impact factor: 9.236
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.